oral glp 1 agonist GLP-1 analogue: perspectives and impact on atherosclerosis in type 2 diabetic patients | Cardiovascular Diabetology new glp 1 agonist In
Description
The clustering of Cardiovascular, Renal, Adipo-Metabolic Eye and Liver disease with type 2 diabetes
4mg weekly dose At 4mg, the weight loss curve steepens dramatically
Topiramate induced acute angle closure glaucoma
Interestingly enough, patients with higher baseline ASCVD risk with tirzepatide therapy showed significantly more reductions in risk [3]
Principally, GLP-1 induces glucose-dependent insulin secretion from pancreatic -cells, 10,11 decreases plasma glucagon concentrations, 11 and delays gastric emptying
J Neuroinflammation
